title: [Innovation instead of imitation -- news in drug therapy].
authors.affiliation: Institut für Klinische Pharmakologie, Medizinische Fakultät, Technische Universität Dresden.
authors.forename: E A
authors.initials: EA
authors.lastname: Mueller
authors.forename: P
authors.initials: P
authors.lastname: Bramlage
authors.forename: W
authors.initials: W
authors.lastname: Böcking
authors.forename: W
authors.initials: W
authors.lastname: Kirch
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000925:Anticoagulants / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001384:Azetidines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001835:Body Weight / Q000187:drug effects; D063387:Cannabinoid Receptor Antagonists; D000068818:Cetuximab; D004358:Drug Therapy / Q000639:trends*; D000069438:Ezetimibe; D000077425:Fondaparinux; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D007328:Insulin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy; D010880:Piperidines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011134:Polysaccharides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011720:Pyrazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000077285:Rimonabant; D016540:Smoking Cessation; D019379:Teriparatide / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D013923:Thromboembolism / Q000517:prevention & control
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000924:Anticholesteremic Agents; D000925:Anticoagulants; D000970:Antineoplastic Agents; D001384:Azetidines; D063387:Cannabinoid Receptor Antagonists; C473734:Exubera; D007004:Hypoglycemic Agents; D007328:Insulin; D010880:Piperidines; D011134:Polysaccharides; D011720:Pyrazoles; D019379:Teriparatide; D000069438:Ezetimibe; D000077425:Fondaparinux; D000068818:Cetuximab; D000077285:Rimonabant